by Eric Christianson | Jun 8, 2022 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Long-Acting Injectable (LAI) Antipsychotics Antipsychotic agents are often discontinued without provider consultation, leading to poorer outcomes and quality of life. Luckily, newer formulations are continually being developed to help address barriers to care and...
by Eric Christianson | Jun 5, 2022 | Dermatology, ENT, Ophthalmology Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Topical corticosteroids are the mainstay for many skin conditions and disorders given their anti-inflammatory, antiproliferative, and immunosuppressive properties. They are available in a variety of strengths and dosage forms, including creams, ointments, lotions,...
by Eric Christianson | Jun 1, 2022 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Though antipsychotics are generally used for long-term treatment of psychiatric conditions, there are several instances where therapy may be stopped altogether. We outline several practice pearls and clinical considerations when determining if antipsychotic tapering...
by Eric Christianson | May 25, 2022 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
On May 13, 2022, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Mounjaro (tirzepatide), a once-weekly injection for the treatment of type 2 diabetes mellitus (T2DM). Pathophysiology of Type 2 Diabetes Mellitus Incretins are the...
by Eric Christianson | May 18, 2022 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Nicotine patches are a useful tool in the management of smoking cessation. The success and tolerability of this form of nicotine replacement does require some pharmacology knowledge. I lay out my most important nicotine patch clinical pearls below. Nicotine Patch...
by Eric Christianson | May 15, 2022 | Cardiovascular Medication and Disease State Clinical Pearls, Clinical Pharmacy News and New Drug Updates, Medication and Disease State Clinical Pearls For Pharmacists
Chlorthalidone and hydrochlorothiazide (podcast) are both thiazide diuretics. They are primarily used in the management of hypertension and occasionally for the management of edema. Hypokalemia, frequent urination, and risk for dehydration are all common adverse...
